Colak Y, Karabay CY, Tuncer I, Kocabay G, Kalayci A, Senates E, Ozturk O, Doganay HL, Enc FY, Ulasoglu C, Kiziltas S. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Eur J Gastroe
Colak Y, Senates E, Ozturk O, Yilmaz Y, Coskunpinar E, Kahraman OT, Sahin O, Zemheri E, Enc FY, Ulasoglu C, Kiziltas S, Kurdas OO, Tuncer I. Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. Hepatogastroenterology
Colak Y, Tuncer I, Senates E, Ozturk O, Doganay L, Yilmaz Y. Nonalcoholic fatty liver disease: a nutritional approach. Metab Syndr Relat Disord. 2012 Jun;10(3):161-6. Epub 2012 Mar 6. Review. PMID: 22394108.
Colak Y, Senates E, Coskunpinar E, Oltulu YM, Zemheri E, Ozturk O, Doganay L, Mesci B, Yilmaz Y, Enc FY, Kiziltas S, Ulasoglu C, Tuncer I. Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease:association with
Colak Y, Senates E, Yesil A, Yilmaz Y, Ozturk O, Doganay L, Coskunpinar E, Kahraman OT, Mesci B, Ulasoglu C, Tuncer I. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine. 2012 Jun 3. PMID: 22661277.
Tuncer I, Harman M, Colak Y, Arslan I, Turkdogan MK. Effect of Ursodeoxycholic acid alone and ursodeoxycholic acid plus domperidone on radiolucent gallstones and gallbladder contractility in humans. Gastroenterol Res Pract. 2012;2012:159438. Epub 2012 May
Yilmaz Y, Eren F, Colak Y, Senates E, Celikel CA, Imeryuz N. Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease. Scand J Gastroenterol. 2012 Dec;47(12):1488-93. doi: 10.3109/00365521.2012.725093. Ep
Senateş E, Colak Y, Yeşil A, Coşkunpinar E, Sahin O, Kahraman OT, Erkalma Şenateş B, Tuncer I. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance an
Yilmaz Y, Ozturk O, Alahdab YO, Senates E, Colak Y, Doganay HL, Coskunpinar E, Oltulu YM, Eren F, Atug O, Tuncer I, Imeryuz N. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease. Dig Liver Dis.
Senateş E, Colak Y, Erdem ED, Yeşil A, Coşkunpınar E, Sahin O, Altunöz ME, Tuncer I, Kurdaş Övünç AO. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women. J Crohns Colitis. 20
Yilmaz Y, Senates E, Ayyildiz T, Colak Y, Tuncer I, Ovunc AO, Dolar E, Kalayci C. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome. Eur J Clin Invest. 2012 Apr;42(4):411-8. doi: 10.1111/j.1365-2362.2011.02597.x. Epu
Yilmaz Y, Eren F, Ayyildiz T, Colak Y, Kurt R, Senates E, Tuncer I, Dolar E, Imeryuz N. Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver st
Colak Y, Senates E, Ozturk O, Yilmaz Y, Zemheri E, Yilmaz Enc F, Ulasoglu C, Aksaray S, Bozbeyoglu SG, Kiziltas S, Kurdas OO, Tuncer I. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein- 5
Colak Y, Ozturk O, Senates E, Tuncer I, Yorulmaz E, Adali G, Doganay L, Enc FY. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Med Sci Monit. 2011 May;17(5):HY5-9. Review. PMID: 21525818.
Senates E, Yilmaz Y, Colak Y, Ozturk O, Altunoz ME, Kurt R, Ozkara S, Aksaray S, Tuncer I, Ovunc AO. Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2011 Aug;9(4):287-90. doi: 10.1089/met
Çolak Y, Tuncer İ, Çağlar E, Barutçu D, Ulaşoğlu C, Kiziltaş Ş. Mitochondrial neurogastrointestinal encephalomyopathy: case report. Turk J Gastroenterol. 2010 Sep;21(3):305-7. PMID: 20931438.
Doganay L, Kiziltas S, Colak Y, Gulluoglu M, Tuncer I. Is the lymphoma risk reduced in viral hepatitis? A cirrhotic patient with triple malignancies. Am J Gastroenterol. 2011 Sep;106(9):1719-20; author reply 1720. doi: 10.1038/ajg.2011.214. PMID: 21897412
Bahat G, Saka B, Colak Y, Tascioglu C, Gulluoglu M. Metastatic gastric melanoma: a challenging diagnosis. Tumori. 2010 May-Jun;96(3):496-7. PMID: 20845816.
Tuncer İ, Çolak Y, Yığıtbaşi R, Zemherı E, Ayaz T, Yorulmaz E, Doğanay L, Öztürk O, Adali G. Mesenteric inflammatory veno-occlusive disease: an unusual cause of colonic ischemia. Turk J Gastroenterol. 2011 Oct;22(5):561-2. PMID: 22234773.
Kiziltaş Ş, Çolak Y, Ulaşoğlu C, Öztürk O, Yorulmaz E, Adali G, Enç F, Tuncer İ. A case of isolated pancreatic tuberculosis mimicking pancreatic carcinoma. Turk J Gastroenterol. 2011 Oct;22(5):566-7. PMID: 22234776.
Colak Y, Tuncer I, Enc FY, Ozturk O, Kiziltas S, Ulasoglu C. Ecstasy induced fatal hepatic failure. J Gastrointestin Liver Dis. 2011 Jun;20(2):215-6. PMID: 21725523.
Bahat G, Colak Y, Saka B, Karan MA, Buyukbabani N. Melanoma metastasis to the breast: a diagnostic pitfall. Cancer Detect Prev. 2009;32(5-6):458-61. PMID: 19588546.
B Bayraktar, Y Çolak, T Eren, S Bölük, Z Özkan, Y Çelik, S Yıldırım, MG Yılmazbaşar. Acute Superior Mesenteric Venous Thrombosis: A Case Report and Review Of Literature. Turkiye Klinikleri J Med Sci 2012;32(5):1405-9.
Yilmaz Y, Colak Y, Kurt R, Senates E, Eren F. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and Back. Tumori. 2013 Jan-Feb;99(1):10-6. doi: 10.1700/1248.13781. PMID: 23548993.
Colak Y , Senates E , Ozturk O , Doganay HL , Coskunpinar E , Oltulu YM , Eren A , Sahin O , Ozkanli S , Enc FY , Ulasoglu C , Tuncer I . Association of serum lipoprotein- associated phospholipase A2 level with nonalcoholic fatty liver disease. Metab Synd
Kocabay G, Karabay CY, Colak Y, Oduncu V, Kalayci A, Akgun T, Guler A, Kirma C. Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: a 2D speckle tracking imaging study. Clin Sci (Lond). 2014 Feb 1;126(4):297-304. doi:10.
Eraslan S, Kizilgul M, Uzunlulu M, Colak Y, Ozturk O, Tuncer I. Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with nonalcoholic fatty liver disease. Minerva Med. 2013 Aug;104(4):447-53. PMID: 24008607.
Karabay CY, Kocabay G, Kalayci A, Colak Y, Oduncu V, Akgun T, Kalkan S, Guler A, Kirma C. Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study. Eur J Gastroenterol Hepatol. 2014 Mar;26(3):325-3
